Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Hemodynamic Effect of Hydroxocabalamin in Refractory Vasodilatory Shock

NCT04964492 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.

NCT NCT04964492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04964492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Hemodynamic Effect of Hydroxocabalamin in Refractory Vasodilatory Shock
Lead sponsor
Centre Hospitalier Universitaire, Amiens
Phase
Observational
Overall status
Completed
Start date
January 15, 2020
Completion date
January 8, 2021
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodynamics, intensive care unit, shock, vasoplegia